Drug reference

Borneol with camphene, cineole, menthol, menthone and pinene

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 119

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

Biliary disorders ▶BY MOUTH ▶Adult: 1–2 capsules 3 times a day, to be taken before food l LESS SUITABLE FOR PRESCRIBING Rowachol ® is less suitable for prescribing.

PDF page 119

Dose and formulations

Medicinal Forms

There can be variation in the licensing of different medicines containing the same drug. Gastro-resistant capsule CAUTIONARY AND ADVISORY LABELS 22 ▶Rowachol (Meadow Laboratories Ltd) Cineole 2 mg, Borneol 5 mg, Camphene 5 mg, Menthone 6 mg, Pinene 17 mg, Menthol 32 mg Rowachol gastro-resistant capsules | 50 capsule P £7.35 7.2 Oesophageal varices Other drugs used for Oesophageal varices Vasopressin, p. 706 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES › VASOPRESSIN AND Gastro-intestinal system ANALOGUES

PDF page 119

Dose text by age group

Adult

1–2 capsules 3 times a day, to be taken before

First-line fragment. Read the complete Indications and Dose section above.

PDF page 119

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

Borneol with camphene, cineole, menthol, menthone and pinene

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 119

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

Biliary disorders ▶BY MOUTH ▶Adult: 1–2 capsules 3 times a day, to be taken before food l LESS SUITABLE FOR PRESCRIBING Rowachol ® is less suitable for prescribing.

PDF page 119

Dose and formulations

Medicinal Forms

PDF page 119

Dose text by age group

Adult

1–2 capsules 3 times a day, to be taken before

First-line fragment. Read the complete Indications and Dose section above.

PDF page 119

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.